• Foretinib: Multikinase Inhibitor for Advanced Cancer Rese...

  2025-10-23

  Foretinib (GSK1363089) stands out as a potent multikinase inhibitor tailored for dissecting VEGF and HGF/Met signaling in cancer models. By enabling precise control over tumor cell growth and metastasis in vitro and in vivo, it elevates experimental rigor and translational value in oncology research workflows.

• SCH772984 HCl: Advancing the Frontiers of ERK1/2 Inhibiti...

  2025-10-22

  This thought-leadership article explores how SCH772984 HCl, a potent and selective ERK1/2 inhibitor, is redefining translational research in BRAF- and RAS-mutant cancers and stem cell biology. By connecting recent mechanistic insights on MAPK pathway inhibition, telomerase regulation, and resistance mechanisms, we offer strategic guidance for researchers aiming to overcome limitations of conventional approaches. The article integrates emerging evidence—including novel chromatin-based control of TERT expression—and positions SCH772984 HCl as a transformative tool for next-generation cancer models.

• SCH772984 HCl: Pioneering Precision in ERK1/2 Inhibition ...

  2025-10-21

  Discover how SCH772984 HCl, a potent ERK1/2 inhibitor, enables advanced MAPK pathway research and addresses resistance in BRAF- and RAS-mutant tumors. This article uniquely explores its mechanistic nuances, translational relevance, and the emerging intersection with DNA repair and telomerase regulation.

168 records 12/12 page Previous First page 上5页 1112